CCL5 production by fibroblasts through a local renin-angiotensin system in malignant melanoma affects tumor immune responses.

Inhibiting renin-angiotensin system restored the therapeutic efficacy of inhibited anti-PD-1 antibodies. Thus, this could be considered a valid approach to enhance the therapeutic efficacy of anti-PD-1 antibodies.